AI channel feed

Biden signs sweep­ing ex­ec­u­tive or­der on AI, with changes com­ing for FDA and health­care

Last year
FDA+

Af­ter years of hype, the first AI-de­signed drugs fall short in the clin­ic

Last year
In Focus

FDA launch­es new dig­i­tal health ad­comm to tack­le in­com­ing com­plex­i­ties

Last year
FDA+
Health Tech

Sanofi adds an­oth­er AI al­liance, this time for bi­o­log­ics with Baidu CEO’s start­up

Last year
Deals
China

AI-dri­ven biotech Iambic snags $100M to en­ter the clin­ic next year in HER2 field

Last year
Financing
Startups

Ex­sci­en­tia ends can­cer study as it fo­cus­es on oth­er tri­als of AI-dri­ven drug can­di­dates

Last year
R&D
Pharma

Ex­clu­sive: 'Faster is­n't bet­ter' — Atom­wise moves from part­ner­ships to pipeline with TYK2 drug

Last year
R&D

FDA+ roundup: Agency re­opens AI dis­cus­sion pa­per for com­ments amid two-day work­shop

Last year
Pharma
FDA+

No­bel Prize win­ner Demis Has­s­abis talks about his vi­sion for Iso­mor­phic and AI’s fu­ture in biotech

Last year
People

Benev­o­len­tAI, Ex­sci­en­tia on the come­back trail af­ter se­cur­ing sep­a­rate AI drug dis­cov­ery deals with Mer­ck KGaA

Last year
Deals

Al­phaFold, meet Al­phaMis­sense: Google Deep­Mind's AI suc­ces­sor pre­dicts how 71M mu­ta­tions cause dis­ease

Last year

Ab­cam founder Jonathan Mil­ner op­pos­es Dana­her buy­out; First Wave tries to find new life in Sanofi drug

Last year
News Briefing

Flag­ship’s AI uni­corn Gen­er­ate rais­es $273M Se­ries C, as first drug in 17-pro­gram pipeline en­ters the clin­ic

Last year
Financing

An­dreessen Horowitz-backed start­up lands $200M for AI-based drug dis­cov­ery

Last year
Financing
R&D

Phar­ma gi­ants tout AI tools as high pri­or­i­ty in half-year earn­ings re­ports

Last year
Pharma

EMA to drug de­vel­op­ers on AI: Car­ry out thor­ough risk as­sess­ments

Last year
Pharma

Causaly, an AI start­up help­ing with pre­clin­i­cal dis­cov­ery, nabs $60M from VCs and for­mer J&J chief Alex Gorsky

Last year
Financing
Startups

Der­ma­vant taps AI for ‘white-glove’ web­site ser­vice for Vta­ma pso­ri­a­sis med

Last year
Pharma
Marketing

Tril­lion-dol­lar part­ner: Re­cur­sion rais­es $50M from Nvidia, stock sky­rock­ets

Last year
Financing

Ex­clu­sive: The se­cret to de­sign­ing pro­tein drugs with AI? Gen­er­ate be­lieves it's cryo-EM at un­prece­dent­ed scale

Last year
R&D
Discovery

Mod­er­na 'laser-fo­cused' on AI, from clin­i­cal de­vel­op­ment to mar­ket­ing: #Can­nes­Lions2023

Last year
Pharma
Marketing

Ex­clu­sive: With $8M, neu­ro start­up Mod­u­lo Bio emerges to test small mol­e­cules for ALS, de­men­tia in CEO’s per­son­al mis­sion

Last year
Financing
Startups

XtalPi inks $250M pact with Lil­ly af­ter Pfiz­er suc­cess

Last year
Deals
China

Vee­va adds gen­er­a­tive AI tool for phar­ma reps as it rolls out new soft­ware plat­form

Last year
Pharma
Marketing
First page Previous page 45678910 Next page Last page
A service from the Financial Times